Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients with asthma \>1 year duration diagnosed according to the GINA guidelines (GINA 2010).
Daily treatment with \> 1000μg beclomethasone dipropionate or equivalent, plus a long acting beta agonist for ≥ 3 months prior to Day 1, that has been stable for at least 4 weeks prior to screening.
Asthma which is not adequately controlled on current treatment
Peripheral blood eosinophil count \< 400/μl at screening
You may not be if
Women of child-bearing potential unwilling to use effective contraception during the study and for 16 weeks after stopping treatment.
Use of other investigational drugs at the time of screening, or within 30 days of screening.
Smokers
Clareo Health | Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
